Sieve based full likelihood approach for the Cox proportional hazards model with applications to immunotherapies trials
Sieve based full likelihood approach for the Cox proportional hazards model with applications to immunotherapies trials
批准号:
10577723
负责人:
SUSAN HALABI
金额:
$22.58万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-02-22 至 2025-01-31
关键词:
AlgorithmsAreaBiologicalCancer PatientCharacteristicsChi-Square DistributionClinical ResearchClinical TreatmentClinical TrialsCox ModelsCox Proportional Hazards ModelsDataDetectionDevelopmentDiseaseEventImmunotherapyIndividualInvestigationLibrariesMalignant NeoplasmsMaximum Likelihood EstimateMethodsMolecularObservational StudyOutcomePatientsPatternPerformancePhase II/III TrialProbabilityProgression-Free SurvivalsRandomizedReportingResearchResidual stateSampling StudiesSurvival AnalysisTest ResultTestingTimeTreatment Efficacydesignexceptional respondersexperiencehazardimmunotherapy trialsimprovedinterestnovelnovel strategiesphase 2 studyphase III trialprecision medicineprimary endpointprimary outcomesemiparametricsimulationstatisticstooltreatment effect
中文摘要
点击翻译按钮获取中文摘要
英文摘要
In clinical studies, the time-to-event outcomes are widely used to evaluate a new treatment
efficacy. When complete randomization is not possible or successful the Cox proportional
hazards model can be used to adjust for the confounding effects and to increase statistical
power. Phase II studies usually have relatively small number, so the survival analysis results are
not very reliable or do not have enough power to detect a positive result of the experimental
treatment. This project aims to provide better survival analysis results compared to existing
methods for small sample studies. Sieve method has becoming a popular approach in
survival analysis, we propose to use the sieve maximum likelihood estimations to improve
survival analysis results for small studies and provide corresponding computing tools for
public use.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Research Triangle Center of Excellence in Regulatory Science and Innovation
-
批准号:10756714
-
项目类别:
-
资助金额:$486.35万
-
财政年份:2023
-
负责人:SUSAN HALABI
-
依托单位:
Interactions of Androgen Production, Uptake and Metabolism on outcome in Castration Resistant Prostate Cancer
-
批准号:10460400
-
项目类别:
-
资助金额:$64.06万
-
财政年份:2021
-
负责人:SUSAN HALABI
-
依托单位:
Interactions of Androgen Production, Uptake and Metabolism on outcome in Castration Resistant Prostate Cancer
-
批准号:10908110
-
项目类别:
-
资助金额:$46.65万
-
财政年份:2021
-
负责人:SUSAN HALABI
-
依托单位:
Serum Androgens as Predictors of Survival in Metastatic Prostate Cancer
-
批准号:8881946
-
项目类别:
-
资助金额:$19.12万
-
财政年份:2015
-
负责人:SUSAN HALABI
-
依托单位:
Prognostic Models of Clinical Outcomes In Men With Castration Resistant Prostate
-
批准号:8298156
-
项目类别:
-
资助金额:$24.23万
-
财政年份:2011
-
负责人:SUSAN HALABI
-
依托单位:
Prognostic Models of Clinical Outcomes In Men With Castration Resistant Prostate
-
批准号:8188071
-
项目类别:
-
资助金额:$21.53万
-
财政年份:2011
-
负责人:SUSAN HALABI
-
依托单位:
Prognostic Models of Clinical Outcomes In Men With Castration Resistant Prostate
-
批准号:8471668
-
项目类别:
-
资助金额:$22.44万
-
财政年份:2011
-
负责人:SUSAN HALABI
-
依托单位:
Prognostic Models of Clinical Outcomes In Men With Castration Resistant Prostate
-
批准号:8681186
-
项目类别:
-
资助金额:$23.16万
-
财政年份:2011
-
负责人:SUSAN HALABI
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: